NASDAQ · Medical - Healthcare Information Services

Carlsmed, Inc. (CARL) Stock

$14.42 +2.63% NASDAQ: CARL Healthcare

Valuation

MetricValue
Price$14.42
Market Cap$392.01M
P/E Ratio-10.49
P/B Ratio4.61
P/S Ratio6.13
EPS (TTM)$0.00
52-Week High$17.23
52-Week Low$8.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-38.06%
ROA-30.75%
ROCE-36.54%
Gross Margin-58.82%
Operating Margin-60.78%
Net Margin-57.42%
Debt/Equity0.26
Current Ratio9.07

Annual Financials (USD)

Metric202320242025
Revenue$14.0M$27.0M$51.0M
Operating Profit$-19.0M$-24.0M$-31.0M
Net Profit$-19.0M$-24.0M$-30.0M
EPS$-4.25$-1.50$-2.12
Op Margin-134.9%-88.8%-60.5%

Balance Sheet (USD)

Metric202320242025
Total Assets$14.0M$52.0M$130.0M
Total Liabilities$60.0M$122.0M$31.0M
Cash$7.0M$40.0M$86.0M
Borrowings$11.0M$17.0M$17.0M

Latest News

Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 22, 2026 Needham Initiates Carlsmed at Buy With $17 Price Target MT Newswires · Jul 1, 2026 Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High? Zacks · May 25, 2026 Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? Zacks · May 22, 2026 Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet Zacks · May 8, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-17.0M$-25.0M$-29.0M
Investing Cash Flow$0$0$-26.0M
Financing Cash Flow$0$0$-5.0M
Net Cash Flow$-14.0M$33.0M$46.0M
Free Cash Flow$-18.0M$-26.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.11
EV / EBITDA-15.01
FCF Yield-8.82%
Quick Ratio8.66
Interest Coverage-28.98
Return 1Y-24.14%
Return 3Y—
Return 5Y—

Ownership

Insiders Held43.73%
Institutions Held40.57%
Institutions Float Held72.10%
Institutional HolderSharesReport Date
Orbimed Advisors LLC.1,252,6002026-03-31
Janus Henderson Group PLC1,227,4522026-03-31
Parkman Healthcare Partners LLC521,1232026-03-31
Blackrock Inc.446,8922026-03-31
Schonfeld Strategic Advisors Llc283,1802026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATECAlphatec Holdings, Inc. $10.67 +3.09% -14.37 $1.64B 0.00%
ENOVEnovis Corporation $17.69 +1.49% -0.96 $1.02B 0.00%
ISRGIntuitive Surgical, Inc. $423.96 +2.06% 45.78 $149.78B 0.00%
KIDSOrthoPediatrics Corp. $21.65 -0.51% -13.19 $556.08M 0.00%
OFIXOrthofix Medical Inc. $9.17 +1.89% -5.92 $370.67M 0.00%

About Carlsmed, Inc.

Carlsmed, Inc. is led by CEO Michael John Cordonnier, employs 100 people, headquartered in US, publicly traded since 2018.

Carlsmed, Inc. (CARL) stock trades at $14.42 with a market capitalization of $392.01M. The stock is valued at a price-to-earnings (P/E) ratio of -10.49, price-to-book of 4.61, price-to-sales of 6.13. Over the past 52 weeks the stock has ranged between $8.50 and $17.23, and currently trades 16.3% below its 52-week high.

On profitability, Carlsmed, Inc. generates a return on equity (ROE) of -38.06%, return on capital employed of -36.54%, an operating margin of -60.78%, a net profit margin of -57.42%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides